ABSTRACT. It is known that several factors, including gender, may influence the expression of multidrug resistance associated proteins 2 (MRP2/ABCC2) in the peripheral blood mononuclear cells (PBMCs). This study aims to compare ABCC2 gene expression in PBMCs of healthy males and females. PBMCs were extracted from 48 females and 44 males, and gene expression was measured using real-time quantitative polymerase chain reaction (real-time QPCR). Multiple housekeeping genes (Actin-β, β2-M, GAPDH) were utilized as endogenous controls. The stability of housekeeping genes was verified using the Excel-based Bestkeeper ® program. Our results showed that expression level of ABCC2 in PBMCs was 1.2-1.4 fold higher in males compared to that in females, depending on the endogenous control(s) used. However, this difference was not statistically significant. When considering using a single endogenous control gene, GAPDH and Actin-β were found to be more suitable than β2-M. Moreover, GAPDH + Actin-β, or the combination of all three housekeeping gene as endogenous control(s) showed greater stability than other endogenous control genes for normalization of ABCC2 expression in PBMCs. This study suggests that ABCC2 expression in PBMCs may be, in part, influenced by gender, and that at least two endogenous control genes should be utilized for gene expression normalization.
INTRODUCTION
Peripheral blood mononuclear cells express a number of membrane-bound ATPdependent drug efflux transporters, including the ATP binding cassette transporter isoform C2 (ABCC2) (Albermann et al., 2005; Fardel et al., 2005) , also known as the multidrug resistance associated proteins 2 (MRP2). This protein is a pharmacological target of a number of drugs (Ito et al., 2001) ; substrates of ABCC2 include various anticancer drugs, immunosuppressants, antibiotics and antiviral drugs targeted for peripheral blood mononuclear cells (PBMCs). The ABCC2 transporter functions as a drug efflux pump, and subsequently prevent accumulation of various substrates in the cells (Gerk and Vore, 2002) . Therefore, differential expression of ABCC2 in PBMCs, including T lymphocytes, macrophages, and monocytes, leads to variability in cellular accumulation of drugs and thus has an effect on therapeutic outcomes (Suzuki and Sugiyama, 2002; Hoffmann and Kroemer, 2004; Fardel et al., 2005; Cascorbi, 2006; Jedlitschky et al., 2006) .
Several factors may exert influence on the inter-individual variability of ABCC2 expression, including gestational age (Meyer et al., 2005) , differences in cell cycle stages (van Der Kolk et al., 2001) , ethnicity (Mor-Cohen et al. 2012) , single nucleotide polymorphisms (SNPs) (van Der Kolk et al., 2001; Meyer et al., 2005; Casobi, 2006; Deo et al., 2012) as well as gender (Rost et al., 2005.; Simon et al., 2006; Suzuki et al., 2006; MacLean et al., 2008) . Studies have shown that expression of ABCC2 protein was 1.5 fold higher in female rat hepatocytes compared to male counterparts as testosterone may reduce ABCC2 protein expression (Rost et al., 2005; Suzuki et al., 2006) . On the other hand, expression of ABCC2 protein in renal cells was significantly higher in males as compared to females (Wang et al., 2012) . Other studies examining ABCC2 protein expression in human liver cells (Deo et al., 2012) and PBMCs (Paintsil et al., 2011) found no effect of gender on its expression. These studies suggested that expression of ABCC2 may be dependent on the tissue/organ in which it is expressed. Currently only limited studies have examined the effect of gender on the expression of ABCC2 in PBMCs with proper endogenous controls used, especially in the Thai population. Therefore, the aim of the present study is to compare the expression levels of ABCC2 in PBMCs between healthy males and females.
MATERIAL AND METHODS

Subjects
All of 92 (48 females, 44 males) healthy Thai volunteers with ranging between18-30 years of age were enrolled in the study. This study was approved by the Institutional Review Boards at Naresuan University, Phitsanulok, Thailand. Individual written consent was obtained from all subjects.
Specimen collection and preparation
Blood was drawn (16 cc) and collected at designated study times in a CPT ® cell preparation tube. PBMCs were isolated by centrifugation at 1700 g for 20 min at room temperature. The isolated PBMCs were immediately processed upon collection, and "flash frozen" using liquid nitrogen. All samples were stored at -70°C until analysis. 
Material and chemicals
RNA isolation and first-strand cDNA synthesis
Total RNA was isolated from 800 μL PBMCs according to the manufacturer protocol (Qiagen ® , Valencia, CA, USA). All RNA samples were eluted in a final volume of 50 μL RNaseFree water (Qiagen ® ). Quantification of total RNA concentrations and the purity of all samples were determined using the NanoDrop ® ND-1000 UV-Vis Spectrophotometer (NanoDrop ® Technologies). Isolated RNA samples were stored at -70°C until analysis.
Reverse transcription was performed with 100 ng total RNA using a cDNA synthesis kits (Stratagene ® , Germany), according to manufacturer instructions. First-strand cDNA was synthesized in a 50-μL reaction mixture containing 10 μL cDNA synthesis master mix (2X), 3 μL oligo (dT) primer, and 1 μL AffinityScript RT/RNase Block enzyme mixture. The PCR cycling protocol is as follows: 25°C for 5 min, 42°C for 45 min, and 95°C for 5 min. The reaction tubes were stored at -20°C for long-term storage until analysis.
Real-time quantitative polymerase chain reaction
Real-time quantitative polymerase chain reaction (qPCR) was carried out with the BioRad iCycler ® (Bio-Rad ® , USA). Expression of each target gene including ABCC2, GAPDH, actin-β, and β-2M in PBMCs was determined. A 20-μL reaction volume containing 10 μL qPCR mastermix, 0.5 μL target gene forward primers, 0.5 μL target gene reverse primers (Table 1) , 1 μL undiluted cDNA, and 8 μL diethyl pyrocarbonate (DEPC) treated water was used. The machine was warmed at 50°C for 2 min and the PCR cycling parameters are as follows: denaturation at 95°C for 10 min, 45 cycles of amplification at 95°C for 10 s, and annealing at 58°C for 10 s. PCR cycles were followed by a dissociation curve analysis to confirm product specificity by increasing temperature in increments of 0.5°C every 5 s. No-template controls were included for each primer pair of each target gene. Each PCR was performed in triplicate. The qPCR products were stored at -20°C and ran on a 2.5% agarose gel to confirm product lengths.
Data were generated with the BIO-RADCFX96 (BIO-RAD ® , USA). Cycle threshold (Ct) values were calculated for all samples using the BIO-RADCFX Software (BIO-RAD ® , USA). To ensure reliable normalization, three housekeeping genes including actin-β, GAPDH, and β-2M were tested as endogenous control(s). 
Evaluation of housekeeping genes
The Excel-based BestKeeper ® program (Pfaffl et al., 2004) was utilized to evaluate the stabilities of all endogenous control(s), and to determine the most suitable housekeeping genes for normalization of ABCC2 gene expression. Individual genes (GAPDH, actin-β, β-2M) as well as the combination of 2 or 3 genes such as GAPDH + actin-β, GAPDH + β-2M, actin-β + β-2M, and GAPDH + actin-β + β-2M, were tested. Stabilities of the individual housekeeping genes were defined by the highest correlation coefficient (r) when compared to the BestKeeeper ® index, and had standard deviation (SD) < 1.
Data and statistical analysis
Descriptive statistical analysis was performed for numerical data. Delta-delta Ct method was used to calculate expression level of ABCC2 relative to no-template control. Housekeeping genes were used for normalization of ABCC2 expression. The Student t-test was used to compare the means of the gene expression between males and females. One way analysis of variance (ANOVA) was utilized to compare the differences in ABCC2 expression among the various endogenous controls(s) used. Univariate analysis was performed to determine the effect of endogenous control(s) and gender on ABCC2 expression. A P value < 0.05 was considered to be statistically significant.
RESULTS
Housekeeping gene stability
The stabilities of endogenous controls (GAPDH, actin-β and β-2M) used to normalize ABCC2 expression level in PBMCs were tested by the Bestkeeper ® program (Table 2) . When considering the stability of a single endogenous control, both actin-β (r = 0.968, SD = 1.50) and GAPDH (r = 0.865, SD = 1.45) were found to be more stable than β-2M (r = 0.867, SD = 1.89). Interestingly, the values of Bestkeeper index ® was increased when 2 or 3 endogenous controls were used for normalization (r = 0.991, -1, SD = 1.45, -1.56). Among these genes, actin-β expression was highly correlated with that of GAPDH (r = 0.874, P = 0.001) and β-2M (r = 0.756, P = 0.001). On the other hand, expression of GAPDH only showed medium correlation with that of β-2M (r = 0.520, P = 0.001). 
Gender difference of the level of ABCC2 expression in PBMCs
As illustrated in Table 3 , ABCC2 expression in PBMCs was dependent on the endogenous controls used for gene expression normalization. Both analysis of variance (ANOVA) and post hoc analysis using Tukey's test showed that the mean levels of ABCC2 expression differed between each normalization methods (P < 0.005). High inter-individuals variability of ABCC2 expression in PBMCs was observed in both male and female volunteers. The degree of variability was also dependent on the types of endogenous control used. However, males mostly showed higher variability in ABCC2 expression (% C.V. = 109.00-315.83) as compared with females (% C.V. = 130.79-179.83), except when utilizing GAPDH as an endogenous control. When comparing the mean levels of ABCC2 expression using independent sample t-tests, males showed higher expression of ABCC2 as compared to females with a male to female ratio of 1.195-1.447 depending on the types of endogenous controls used. However, the results were not statistically significant (P > 0.05). Interestingly, univariate analysis showed that gender was correlated with ABCC2 expression level (P = 0.006) while types of endogenous control(s) had no influence on the level of ABCC2 in PBMCs (P > 0.05). S.D.; Standard deviation, C.V.; Coefficient of variation β2-M: Beta-2-microglobulin GAPDH: Glyceraldehyde-3-phosphate dehydrogenase Actin-β: Beta actin. *The levels of ABCC2 expression were statistically different when normalized to different types of endogenous control (P < 0.001) using one way ANOVA. However, univariate analysis showed that gender, and not types of endogenous control, influenced the level of the expression, (P = 0.006). # The levels of ABCC2 expression between males and females were comparable using independent t-tests (P > 0.05).
DISCUSSION
Stability of endogenous control(s)
GAPDH, Actin-β and β2-M are common housekeeping genes that are widely used for gene expression normalization. A previous study examining the stability of 10 housekeeping genes in lymphocytes found that β2-M was more stable than GAPDH or Actin-β (Vandesompele et al., 2002) . In contrast, the present study showed that GAPDH and Actin-β were more stable compared to β2-M, which is supported by our previous study (Sudchada et al., 2010) . However, similar to the present study, previous studies (Vandesompele et al., 2002; Sudchada et al., 2010) suggested more than one gene should be used for normalization during gene expression analysis. These findings suggest the endogenous controls used to normalize target genes may affect interpretation of the results. Therefore, the endogenous controls should be validated prior to target gene analysis.
In the present study, we also found that determination of ABCC2 expression using β2-M or Actin-β as a single endogenous control or combined with other housekeeping genes show higher variability between males and females, which is supported by our previous findings (Sudchada et al., 2010) . To allow more accurate gene expression profiles, endogenous controls should be carefully considered and validated.
Comparing levels of ABCC2 expression between males and females
Various factors may influence on the expression of ABCC2, including gender. Results from this study suggests that gender may affect ABCC2 gene expression in PBMCs. Therefore, gender may potentially correlate with differences in drug response to PBMC-targeted ABCC2 substrates.
A study conducted in Sprague-Dawley (SD) rats using immunoblot analysis reported that female rats had 1.5 fold greater ABCC2 protein expression compared to males (P < 0.001). It is possible that testosterone can reduce ABCC2 protein expression (P < 0.042) (Rost et al., 2005) . Similar results were found in another rat study using western blot analysis (Suzuki et al., 2006) . Suzuki et al. (2006) showed that protein expression of ABCC2 was greater in female rats as compared to male rats, which was also reversely correlated with doxorubicin levels in liver cells. In contrast, another study investigating the correlation between plasma ofloxacin concentration and ABCC2 protein expression in renal cells found that ABCC2 expression was greater in male rats as compared with female rats (P < 0.05) (Wang et al., 2012) . These results indicate that ABCC2 protein expression may vary between male and female rats in different organs.
A study in liver cells from the Human Liver Bank in University of Washington School of Pharmacy reported that gender had no influence on expression of ABCC2 in hepatocytes (Deo et al., 2012) . Similar finding was observed in a study on white blood cells extracted from 9 healthy volunteers (5 females, 4 males) using GAPDH as an endogenous control (Paintsil et al., 2011) . The study also observed that ABCC2 expression was not correlated with metabolite levels of ethynylstavudine and lamivudine, but was tentatively to be correlated with zidovudine (P > 0.05) (Paintsil et al., 2011) . However, this study was conducted on a small number of subjects with limited statistical power (Paintsil et al., 2011) . In contrast, the present study found that gender may potentially influence ABCC2 expression in PBMCs, where males showed greater levels of ABCC2 expression compared to females.
We found high variabilities in the level of ABCC2 expression in this study , which is supported by previous findings indicating that inter-individual variability was two folds higher than the median ABCC2 expression in PBMCs (Liptrott et al., 2008) . Furthermore, we observed higher variability of ABCC2 expression in males as compared to females. Similarly, a previous study found that males had greater variability of protein ABCC2 expression in liver than females (MacLean et al., 2008) . On the other hand, another study found that females had greater variability in PBMC ABCC2 expression than males (Paintsil et al., 2011) .
In summary, this study provides evidence that gender may correlate expression level of ABCC2 in PBMCs, which may partially account for the inter-variability of pharmacokinetics and pharmacodynamics of ABCC2 substrates in PBMCs. However, further studies on the protein expression in PBMCs and other potential factors such as SNPs are warranted.
